| | Is there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis?Received 28 October 2009; accepted 28 October 2009. published online 03 December 2009. Abbreviations: AMA, antimitochondrial antibody, MRS, Mayo risk score, PBC, primary biliary cirrhosis, TGF-β, transforming growth factor-β, TM, tetrathiomolybdate, TNF-α, tumor necrosis factor-α, UDCA, ursodeoxycholic acid No abstract is available. To read the body of this article, please view the Full Text online. |
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minn  Reprint requests: Keith D. Lindor, MD, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905
PII: S1931-5244(09)00323-5 doi:10.1016/j.trsl.2009.10.006 © 2010 Mosby, Inc. All rights reserved. | |
|
|
